Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches (CRUZA)

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
University of Massachusetts, Boston
Information provided by (Responsible Party):
Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01740219
First received: November 30, 2012
Last updated: August 21, 2013
Last verified: August 2013
  Purpose

This research study aims to develop an organizational-level intervention to enable communities to adopt, adapt, implement and sustain evidence-based interventions (EBIs) to address cancer disparities among Latinos. The investigators partner with faith-based organizations, since they play a highly prominent role in Latino community life. This three-phase study will: (1) improve understanding of the organizational infrastructure, skills and resources required by Latino churches to implement EBIs for cancer control, (2) develop a capacity-building intervention; and (3) test the intervention's effectiveness in a randomized trial.


Condition Intervention
Cancer
Behavioral: Capacity Enhancement
Behavioral: Standard Dissemination

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Promoting the Utilization of Cancer Early Detection Methods Among Latinos in Church: a Faith-based Approach

Resource links provided by NLM:


Further study details as provided by Dana-Farber Cancer Institute:

Primary Outcome Measures:
  • Implementation [ Time Frame: 3-months ] [ Designated as safety issue: No ]
    Number and types of interventions offered


Estimated Enrollment: 348
Study Start Date: September 2011
Estimated Study Completion Date: September 2013
Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Capacity Enhancement Behavioral: Capacity Enhancement
Churches in the Capacity Enhancement intervention will be invited to work with CRUZA staff over the course of a three month intervention to implement health promotion activities in their church and participate in capacity-building educational workshops. Participants may also receive technical assistance from Health Educators in order to implement their cancer education activities.
Experimental: Standard Dissemination Behavioral: Standard Dissemination
Churches in the Standard Dissemination arm will receive program materials with information about cancer prevention/early detection and health resources.

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Parishes eligible for the Randomized trial are those that are: Roman Catholic, located in Massachusetts, offer religious services in Spanish, and have taken part in the organizational survey.

Exclusion Criteria:

  • Not Roman Catholic, not located in Massachusetts, don't offer religious services in Spanish, and have not participated in the organizational survey.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01740219

Locations
United States, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
University of Massachusetts Boston
Boston, Massachusetts, United States, 02125
Sponsors and Collaborators
Dana-Farber Cancer Institute
University of Massachusetts, Boston
Investigators
Principal Investigator: Jennifer D Allen, ScD Dana-Farber Cancer Institute
Principal Investigator: Maria Idali Torres, PhD University of Massachusetts, Boston
  More Information

Additional Information:
No publications provided

Responsible Party: Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier: NCT01740219     History of Changes
Other Study ID Numbers: 19674
Study First Received: November 30, 2012
Last Updated: August 21, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Dana-Farber Cancer Institute:
Health promotion
Female
Religion and medicine
Hispanic Americans
Randomized controlled trial
Program evaluation
Neoplasms/prevention & control
Mass screening
Male
Preventive Health Services/methods
Adult
Organizations

ClinicalTrials.gov processed this record on August 18, 2014